Topical Wound Agents Market Size & Share 2024 to 2032
Market Size by Product (Creams, Gels, Sprays), Drug Type (Antiseptics, Antibiotics, NSAIDS), Application (Chronic & Acute Wounds), Distribution Channel.
Report ID: GMI7712
|
Published Date: December 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Topical Wound Agents Market Size
Topical Wound Agents Market size was valued at USD 1.7 billion in 2023 and is anticipated to grow at a CAGR of over 7.7% between 2024 and 2032. Topical wound agents refer to the management and treatment of wounds using products that are applied directly to the skin surface. The rising prevalence of both chronic and acute wounds functions as a driving factor for the industry gains. For instance, in the U.S., it is estimated that approximately 6 million people suffer from chronic wounds, annually. These wounds includes diabetic foot ulcers and pressure ulcers, venous ulcers, arterial ulcers, among others.
Topical Wound Agents Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Moreover, the demand for topical wound agents is fueled by factors such as the growing geriatric population base prone to chronic conditions and impaired wound healing. Additionally, increased surgical procedures, surge in awareness regarding appropriate wound care practices, along with the availability of cutting-edge treatments.
Topical Wound Agents Market Trends
The increasing number of surgical procedures worldwide is leading to a higher demand for wound care products, including topical wound agents, to prevent surgical site infections and promote rapid healing. As surgical treatments become more accessible and affordable globally, more surgeries are estimated to be performed, leading to a higher demand for wound care products. Moreover, technological advancements in surgical techniques and the availability of advanced wound care, which accounted for USD 11.3 billion in 2023.
Topical Wound Agents Market Analysis
The industry by product is categorized into creams, gels, sprays, and other products. The creams segment garnered USD 667 million revenue size in the year 2023.
Based on drug type, the topical wound agents market unfolds into antiseptics, antibiotics, nonsteroidal anti-inflammatory agents (NSAIDS), and other drug types. The antiseptics segment garnered a market share of 34% in 2023.
Based on application, the topical wound agents market is segmented into chronic wounds and acute wounds. The chronic wound segment held 79% industry share in 2023.
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. The hospital pharmacies segment is estimated to account for USD 1.3 billion by 2032.
Based on end-use, the topical wound agents market is segmented into hospitals, clinics, and other end-users. The hospitals segment garnered USD 734 million revenue size in the year 2023.
U.S. topical wound agents market accounted for USD 710 million revenue size in 2023.
Topical Wound Agents Market Share
The topical wound agents industry is consolidated, with key players including Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd, Mylan N.V., AstraZeneca, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial position in the market. For instance, in February 2023, SERDA Therapeutics, a biopharmaceutical company, announced the submission of an Investigational New Drug Application (IND) to the U.S. FDA for its flagship product, SN514 hydrogel. SN514 hydrogel is a groundbreaking enzymatic wound debriding agent developed by the company. This move substantially broadened company’s array of products, leading to increased revenue streams for the company.
Topical Wound Agents Market Companies
Some of the eminent market participants operating in the topical wound agents industry include:
Topical Wound Agents Industry News:
Topical wound agents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 – 2032 (USD Million)
By Drug Type, 2018 – 2032 (USD Million)
By Application, 2018 – 2032 (USD Million)
By Distribution Channel, 2018 – 2032 (USD Million)
By End-use, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →